About Caidya
Caidya is a company based in Morrisville (United States) founded in 2003. Caidya has raised $373 million across 5 funding rounds from investors including Fidelity Investments, Kaiser Permanente and Zai Lab. The company has 351 employees as of December 31, 2022. Caidya operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Morrisville, United States
- Employees 351 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clinipace Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$373 M (USD)
in 5 rounds
-
Latest Funding Round
$165 M (USD), Private Equity Round
Jan 13, 2025
-
Investors
Fidelity Investments
& 12 more
-
Employee Count
351
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Caidya
Caidya has successfully raised a total of $373M across 5 strategic funding rounds. The most recent funding activity was a Private Equity Round of $165 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Caidya
Caidya has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, Kaiser Permanente and Zai Lab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investment firm focused on building transformational companies.
|
Locked | Locked | Locked | |
|
UK life science startups are invested in by SpringHill Management.
|
Locked | Locked | Locked | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Locked | Locked | Locked |
Investor details for Caidya
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Caidya
Investment portfolio details for Caidya
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Caidya
Detailed financials for Caidya
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Caidya Comparisons
Peer comparison for Caidya
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Caidya
Caidya operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of Caidya
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Caidya
Complete news archive for Caidya
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caidya
Caidya was founded in 2003 and raised its 1st funding round 13 years after it was founded.
Caidya is headquartered in Morrisville, United States.
Caidya is a funded company, having raised a total of $373M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Caidya is 351.
Caidya was established in 2003 and is headquartered in Morrisville, United States. As a contract research organization, focus is placed on clinical development for phases II and III trials within the pharmaceutical and biotechnology sectors. Regulatory affairs services are also delivered to assist with compliance and approval processes. Operations support clients through structured trial management and advisory expertise in a regulated environment.
Caidya's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Caidya has 13 investors. Key investors include Fidelity Investments, Kaiser Permanente, Zai Lab, Qiming Venture Partners, and Rubicon Founders.